KRTL BioTech

Latest News on private equity markets

Strong U.S. jobs growth expected in May, trade tensions a threat

U.S. job growth likely increased solidly in May, with wage gains expected to pick up, showing strength in the labor market before an escalation in trade tensions that analysts have cautioned could pressure an already slowing economy.



5 years ago

Google flags U.S. national security risks from Huawei ban: FT

Alphabet Inc's Google has warned if the U.S. administration moves ahead with sweeping ban on Huawei Technologies Co Ltd, it risks compromising national security, the Financial Times reported on Thursday.



5 years ago

Walmart relaunches service to deliver groceries to shoppers' refrigerators

Walmart Inc will restart a service that offers the delivery of groceries directly to shoppers' refrigerators - part of its attempts to find unconventional ways to offer cheap and rapid delivery of online orders.



5 years ago

Sanofi appoints Paul Hudson as CEO to replace retiring Brandicourt

French pharma giant Sanofi appointed Paul Hudson as chief executive to replace Olivier Brandicourt, who will retire in September, the company said on Friday.



5 years ago

Toyota speeds up electrified vehicle schedule as demand heats up

Toyota Motor Corp aims to have half of its global sales from electrified vehicles by 2025, five years ahead of schedule, and said it will tie up with Chinese battery makers to accommodate an accelerated shift to electric power.



5 years ago

Exclusive: Facebook suspends app pre-installs on Huawei phones

Facebook Inc is no longer allowing pre-installation of its apps on Huawei phones, the latest blow for the Chinese tech giant as it struggles to keep its business afloat in the face of a U.S. ban on its purchase of American parts and software.



5 years ago

Swiss drugmaker Novartis names new drug division head

Swiss pharmaceuticals giant Novartis named Marie-France Tschudin head of its main drugs business after its previous manager, Paul Hudson, was poised to take the CEO position at French drugmaker Sanofi.



5 years ago

France did not come out well in FCA-Renault deal: Italy's Di Maio

Italy's Industry Minister Luigi Di Maio blamed the French state for derailing merger talks between Fiat Chrysler and rival Renault saying Paris had come out poorly in the situation.



5 years ago

Drugmaker Sanofi appoints Novartis executive Hudson as new CEO

French pharma giant Sanofi has appointed Paul Hudson as chief executive to replace Olivier Brandicourt, who will retire in September, the company said on Friday.



5 years ago

Asia shares up on policy easing hopes, yuan slips on PBOC signals

Asian shares were slightly higher on Friday on expectations global central banks will soon embark on an easing cycle in the face of international trade frictions and fears of a world recession.



5 years ago

Germany's Opel town shows struggle for Europe to plug in electric cars

Carmakers and policymakers in Europe are staking their futures on a race to electric vehicles. But the vast charging network needed to sustain their vision is patchy, and it's not clear who'll pay for it.



5 years ago

Qatar Airways to seek compensation from Boeing over MAX grounding

Qatar Airways plans to seek compensation from Boeing over the grounding of three 737 MAX aircraft by Italian airline Air Italy, where the Qatari company is a major shareholder, group chief executive Akbar al-Baker told Reuters.



5 years ago

Drugmaker Sanofi appoints Novartis' Hudson as CEO

Sanofi has appointed Novartis executive Paul Hudson to replace CEO Olivier Brandicourt who will retire in September, France's biggest drugmaker said on Friday.



5 years ago

Gucci parent Kering moves to tighten grip on e-commerce

Kering, owner of brands including Gucci, will tighten its grip on its e-commerce operations, focusing on its own branded sites to sell its luxury products or ventures where it can control its image and client data.



5 years ago

Germany's Stada buys six of GSK's consumer brands, eyes further deals

Private equity-backed generic drugmaker Stada said on Friday it would buy six consumer healthcare products from British drugmaker GlaxoSmithKline to bolster its presence in Europe.



5 years ago